Sa2005 – Expert Consensus on Managing Iron Deficiency Anaemia in Patients with Gastrointestinal Bleeding – a European Edelphi Survey

Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications

“…This is also supported by other recent studies, including an e-Delphi survey for IDA in gastrointestinal bleeding concluded "that current use of iron therapy by experts in the field is driven by clinical and cost-orientated considerations, rather than by clinical assessment and therapeutic targets or treatment thresholds". 70 A recent meta-analysis of the safety of IV iron compounds in IBD treatments found that FCM was associated with fewer adverse events, although, its statistical significance remains unproven due to the lack of data from randomized controlled trials. 71 A cost-effectiveness study in the Nordic countries suggested that implementing the ESC guidelines for the treatment of iron deficiency in heart failure using FCM would improve both health-related QOL and reduce healthcare costs.…”